Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
To meet the requirements for rapid tumor growth, a complex array of non-neoplastic cells are recruited to the tumor microenvironment. These cells facilitate tumor development by providing matrices, cytokines, growth factors, as well as vascular networks for nutrient and waste exchange, however their precise origins remain unclear. Through multicolored tissue transplant procedures; we have quantitatively determined the contribution of bone marrow-derived and adipose-derived cells to stromal populations within syngeneic ovarian and breast murine tumors. Our results indicate that subpopulations of tumor-associated fibroblasts (TAFs) are recruited from two distinct sources. The majority of fibroblast specific protein (FSP) positive and fibroblast activation protein (FAP) positive TAFs originate from mesenchymal stem/stromal cells (MSC) located in bone marrow sources, whereas most vascular and fibrovascular stroma (pericytes, α-SMA(+) myofibroblasts, and endothelial cells) originates from neighboring adipose tissue. These results highlight the capacity for tumors to utilize multiple sources of structural cells in a systematic and discriminative manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“MSC can be mobilized and recruited to active tumor sites, where they can incorporate into the tumor’s microenvironment [5, 68, 100–103].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725 · cited 1×
“The existence of a circulating bone marrow-derived endothelial progenitor (BM EPC) has been a topic of controversy for the past decade, dating back to its initial description by Asahara and colleagues in 1997 [39].”
BackgroundMultilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., & Hedrick, M. H. (2001) · Tissue Engineering · doi:10.1089/107632701300062859 · Cited by 7,956 · cited 1×
“Within the stromal fraction of WAT, progenitors with a similar phenotype, proliferative rate and differential capacity to BM MSC have been identified [47,54].”
BackgroundOverweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696 · cited 1×
“Obesity has been determined as a predisposing factor for cancer development and is associated with poor prognosis of certain cancer types [50].”
BackgroundKern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,253 · cited 2×
“BM EPC have been reported to contribute significantly to tumor vasculature in many investigations [6,32,33].”
BackgroundAdipose-derived stem cells for regenerative medicine
Gimble, J. M., Katz, A. J., & Bunnell, B. A. (2007) · Circulation Research · doi:10.1161/01.res.0000265074.83288.09 · Cited by 2,332 · cited 1×
“Within the stromal fraction of WAT, progenitors with a similar phenotype, proliferative rate and differential capacity to BM MSC have been identified [47,54].”
BackgroundDistinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860 · cited 2×
“BM EPC have been reported to contribute significantly to tumor vasculature in many investigations [6,32,33].”
BackgroundDeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
De Palma, M., Venneri, M. A., Galli, R., Sergi, L. S., Politi, L. S., Sampaolesi, M., & Naldini, L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.002 · Cited by 1,311
Research works printed but not linked: 1
- Studeny M Marini FC Zompetta C Champlin RE Filder IJ 2001 Bone marrow derived mesenchymal stem cells serve as precursors for stromal fibroblasts in malignant tumors and show potential for cancer therapy. Blood 9 697a
Cited by
Items 101–200 of 370
Jayaprakasam, V. S., Paroder, V., Gibbs, P., Bajwa, R., Gangai, N. C., Sosa, R. E., Petkovska, I., Pernicka, J. S. G., Fuqua, J. L., Bates, . D. B., et al. (2021) · European Radiology · doi:10.1007/s00330-021-08144-w · Cited by 81
Strong, A. L., Pei, D. T., Hurst, C. G., Gimble, J. M., Burow, M. E., & Bunnell, B. A. (2017) · Stem Cells International · doi:10.1155/2017/9216502 · Cited by 77
Escobar, P., Bouclier, C., Serret, J., Bièche, I., Brigitte, M., Caicedo, A., Sanchez, E., Vacher, S., Vignais, M., Bourin, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4732 · Cited by 82
“It was - 13 - shown that chemokines produced by adipose tissue derived stromal cells (ADSC), that have close properties with BM-MSCs, can enhance the proliferation of cancer cells [46].”
BackgroundInfluentialTouboul, C., Lis, R., Al Farsi, H., Raynaud, C. M., Warfa, M., Althawadi, H., Mery, E., Mirshahi, M., & Rafii, A. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-28 · Cited by 75
“Several authors [22-24] showed that MSCs promoted tumor growth through increased micro-vascularization, stromal networks, and production of tumor stimulating paracrine factors.”
BackgroundNovel hepatocellular carcinoma molecules with prognostic and therapeutic potentials
Scaggiante, B., Kazemi, M., Pozzato, G., Dapas, B., Farra, R., Grassi, M., Zanconati, F., & Grassi, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i5.1268 · Cited by 78
Mesenchymal stromal cells as cancer promoters
Antoon, R., Overdevest, N., Saleh, A. H., & Keating, A. (2024) · Oncogene · doi:10.1038/s41388-024-03183-1 · Cited by 75
Romano, V., Belviso, I., Venuta, A., Ruocco, M. R., Masone, S., Aliotta, F., Fiume, G., Montagnani, S., Avagliano, A., & Arcucci, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105283 · Cited by 83
“The tumor stroma, whose composition varies significantly between different tumor types and during cancer evolution [55], deeply influences many hallmarks of cancer [56].”
BackgroundT-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
Wang, Z., Li, B., Ren, Y., & Ye, Z. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00353 · Cited by 73
Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment
Darestani, N. G., Rudova, A., Al-Gazally, M. E., Zekiy, A. O., Ansari, M. J., Zabibah, R. S., Jawad, M. A., Al-Shalah, S. A. J., Rizaev, J. A., Alnassar, Y. S., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-022-01012-0 · Cited by 115
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
Brennen, W. N., Denmeade, S. R., & Isaacs, J. T. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0151 · Cited by 80
“1; Mishra et al. 2008, 2009, Paunescu et al. 2011, Kidd et al. 2012, Jung et al. 2013), which have been implicated in nearly all stages of prostate cancer carcinogenesis, including initiation, progression, invasion, and metastasis (Chung 1991, Olumi et al. 1999, Bhowmick et al. 2004, Franco et al.…”
InfluentialCancer Risk after Fat Transfer: A Multicenter Case-Cohort Study
Myckatyn, T. M., Wagner, I. J., Mehrara, B. J., Crosby, M. A., Park, J. E., Qaqish, B. F., Moore, D. T., Busch, E. L., Silva, A. K., Kaur, S., et al. (2016) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000002838 · Cited by 79
“62) 25 25 TNM stage I 585 (49) 77 (34) 508 (52) II 448 (37) 92 (41) 356 (37) III 164 (14) 56 (25) 108 (11) Receptors HER2Neu+ 215 (20) 29 (13) 205 (22) ER+ 875 (74) 134 (60) 741 (78) PR+ 713 (61) 101 (46) 612 (64) Treatment Adjuvant radiation therapy 319 (27) 110 (49) 209 (22) Adjuvant chemotherapy 689 (58) 153 (68) 5…”
Miyazaki, Y., Oda, T., Inagaki, Y., Kushige, H., Saito, Y., Mori, N., Takayama, Y., Kumagai, Y., Mitsuyama, T., & Kida, Y. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-84058-3 · Cited by 69
Cancer-Associated Fibroblasts and T Cells: From Mechanisms to Outcomes
Baker, A. T., Abuwarwar, M. H., Poly, L., Wilkins, S., & Fletcher, A. L. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001203 · Cited by 67
“CAFs derive from other populations, including circulating mesenchymal cells (13–15), adipose (16), pericytes (17), and endothelial cells undergoing mesenchymal transition (18, 19).”
BackgroundTargeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits
Maneshi, P., Mason, J. E., Dongre, M., & Öhlund, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.787485 · Cited by 75
“, 2008), neighboring adipose tissue (Kidd et al., 2012), or arise from the transdifferentiation of other cell types such as pancreatic stellate cells (PSCs) (Bachem et al.”
BackgroundSugrue, T., Brown, J. A. L., Lowndes, N. F., & Ceredig, R. (2012) · Stem Cells · doi:10.1002/stem.1222 · Cited by 67
“VEGF, IL-8 and TGF- ) which induce MSC homing and subsequent conversion into tumorassociated fibroblasts (TAFs) [43-45].”
BackgroundBone Marrow–Derived Mesenchymal Stromal Cells Promote Survival and Drug Resistance in Tumor Cells
Bergfeld, S. A., Blavier, L., & DeClerck, Y. A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0400 · Cited by 63
“Recently, there has been increased evidence that bone marrow-derived mesenchymal cells also contribute to tumorigenesis and metastasis, but their role has been less well characterized (3, 4).”
BackgroundMSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential
D’souza, N., Burns, J. S., Grisendi, G., Candini, O., Veronesi, E., Piccinno, S., Horwitz, E. M., Paolucci, P., Conte, P., & Dominici, M. (2012) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2012_150 · Cited by 61
To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells
Droujinine, I. A., Eckert, M. A., & Zhao, W. (2013) · Oncotarget · doi:10.18632/oncotarget.1040 · Cited by 69
“A large proportion of MSCs contribute to the TAF population, raising the possibility of MSC involvement in activation of this pathway (6).”
BackgroundInfluentialBersani, F., Lee, J. W., Yu, M., Morris, R. T., Desai, R. N., Ramaswamy, S., Toner, M., Haber, D. A., & Parekkadan, B. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1809 · Cited by 65
“The importance of the microenvironment in metastatic progression is well established, but our understanding of the precise contribution of specific factors and cell populations, which have been extensively studied at the primary tumor level (38, 39), is limited at secondary sites.”
Takiguchi, G., Nishita, M., Kana, K., Kakeji, Y., & Minami, Y. (2015) · Cancer Science · doi:10.1111/cas.12871 · Cited by 64
Son, G. M., Kwon, M.-S., Shin, D., Shin, N., Ryu, D., & Kang, C. (2019) · Medicine · doi:10.1097/md.0000000000015164 · Cited by 69
“a-SMA expressing myofibroblasts are representative of activated CAFs, as well as wound healing.([7]) FAPa is a type II integral membrane protein belonging to the”
BackgroundOsman, A., Afify, S. M., Hassan, G., Fu, X., Seno, A., & Seno, M. (2020) · Cancers · doi:10.3390/cancers12040879 · Cited by 63
“Adipocytes were shown to differentiate into CAFs in breast cancer [90].”
BackgroundRole of the tumor microenvironment in cancer hallmarks and targeted therapy (Review)
Naser, R., Fakhoury, I., El‑Fouani, A., Abi‑Habib, R., & El‑Sibai, M. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5471 · Cited by 61
Fibrocytes and fibroblasts—Where are we now
Chong, S. G., Sato, S., Kolb, M. R. J., & Gauldie, J. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.105595 · Cited by 69
Kikuchi, S., Yoshioka, Y., Prieto‐Vila, M., & Ochiya, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102584 · Cited by 65
“This environment also comprises a heterogeneous group of cells, including stromal cells and cancer cells [94].”
BackgroundPleyer, L., Valent, P., & Greil, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071009 · Cited by 65
“Alternatively, mouse models have shown that the tumor-attracted MSPCs may also differentiate into CAFs in the case of BM origin [499], or into vascular ECs in the case of adipose tissue-derived MSPCs [500], but this remains to be demonstrated in vivo in humans.”
BackgroundThe systemic hallmarks of cancer
Paul, D. (2020) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2020.63 · Cited by 73
“A research team from MD Anderson have shown that the origin of these cancer-associated fibroblasts is primarily the bone marrow([82]) but their origin and function within the tumor stroma varies([83]).”
BackgroundZhang, X., Tu, H., Yang, Y., Fang, L., Wu, Q., & Li, J. (2017) · Stem Cells International · doi:10.1155/2017/1758139 · Cited by 59
“…University, 1 Minde Road, Nanchang, Jiangxi 330006, China Correspondence should be addressed to Jian Li; thj127900@163.com Received 25 October 2016; Accepted 19 February 2017; Published 9 March 2017 Academic Editor: Benedetta Bussolati Copyright © 2017 Xiaoyan Zhang et al.This is an open…”
Mesenchymal stem cells and the embryonic reawakening theory of BPH
Brennen, W. N., & Isaacs, J. T. (2018) · Nature Reviews Urology · doi:10.1038/s41585-018-0087-9 · Cited by 67
Kwak, M. S., Lee, H. H., Yang, J. M., Cha, J. M., Jeon, J. W., Yoon, J. Y., & Kim, H. I. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.619803 · Cited by 68
“The tumor microenvironment is a heterogeneous population of cells composed of tumor cells and tumor-associated stroma, which promote tumor growth, development, and propagation, surrounding non-cancer or stromal cells recruited by the tumor (36 – 39).”
BackgroundOrigin and pharmacological modulation of tumor‐associated regulatory dendritic cells
Zhong, H., Gutkin, D. W., Han, B., Ma, Y., Keskinov, A. A., Shurin, M. R., & Shurin, G. V. (2014) · International Journal of Cancer · doi:10.1002/ijc.28590 · Cited by 61
3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment
Franchi-Mendes, T., Eduardo, R., Domenici, G., & Brito, C. (2021) · Cancers · doi:10.3390/cancers13184610 · Cited by 68
Zhang, Y., Zhao, Z., Huang, W., Kim, B. S., Li, L., Li, X., Hou, M., Li, L., Zhang, Y., Xi, W., et al. (2024) · Current Gene Therapy · doi:10.2174/0115665232331353240911080642 · Cited by 67
Cancer associated fibroblasts in hematological malignancies
Raffaghello, L., Vacca, A., Pistoia, V., & Ribatti, D. (2014) · Oncotarget · doi:10.18632/oncotarget.2661 · Cited by 61
“CAF activation is commonly accompanied by the acquisition or upregulation of specific markers which can be classified in four groups: i) the fibroblast activation markers, which include fibroblast specific protein (FSP) and fibroblast activation protein (FAP); ii) the aggressiveness markers thrombospondin-1 (TSP-1), t…”
BackgroundMesenchymal stromal cells: radio‐resistant members of the bone marrow
Sugrue, T., Lowndes, N. F., & Ceredig, R. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2012.61 · Cited by 58
Koellensperger, E., Bonnert, L.-C., Zoernig, I., Marmé, F., Sandmann, S., Germann, G., Gramley, F., & Leimer, U. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0579-1 · Cited by 62
“The surrounding adipose tissue with its ADSC-containing stromal vascular fraction is supposed to especially contribute to the vascular and fibrovascular stroma of adjacent breast tumors [8].”
Extracellular Vesicles and Cancer: A Focus on Metabolism, Cytokines, and Immunity
Lucchetti, D., Tenore, C. R., Colella, F., & Sgambato, A. (2020) · Cancers · doi:10.3390/cancers12010171 · Cited by 62
“The tumor microenvironment (TME) comprises a heterogeneous population of cancer cells and nearby stromal cells recruited by the tumor (tumor-associated stromal cells, TASCs) [24].”
BackgroundThe Dynamic Roles of Mesenchymal Stem Cells in Colon Cancer
Wang, S., Miao, Z., Yang, Q., Wang, Y., & Zhang, J. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/7628763 · Cited by 55
“It is reflected by the interaction of tumor cells and stroma cells adjoining, and is mainly composed by inflammatory cells and fibroblasts [59, 60].”
BackgroundRubinstein-Achiasaf, L., Morein, D., Ben-Yaakov, H., Liubomirski, Y., Meshel, T., Elbaz, E., Dorot, O., Pichinuk, E., Gershovits, M., Weil, M., et al. (2021) · Cancers · doi:10.3390/cancers13061472 · Cited by 61
“Moreover, in line with findings demonstrating that CAFs that are derived from BM-MSCs expressed low levels of PDGFRa, COL1A1, and FSP-1 [49], the BM-MSCs used in our studies demonstrated higher levels of these three genes compared to the CAF-like cells obtained following continuous stimulation with TNFα + IL-1β (Figur…”
BackgroundInfluentialEpigenetic regulation of cancer-associated fibroblast heterogeneity
Kehrberg, R. J., Bhyravbhatla, N., Batra, S. K., & Kumar, S. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188901 · Cited by 60
Berg, E. L., Hsu, Y.-C., & Lee, J. A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.01.013 · Cited by 66
IFN-γ-Secreting-Mesenchymal Stem Cells Exert an Antitumor Effect In Vivo via the TRAIL Pathway
Yang, X., Du, J., Xu, X., Xu, C., & Song, W. (2014) · Journal of Immunology Research · doi:10.1155/2014/318098 · Cited by 52
“reported that BM- and adipose-derived MSCs may be recruited by ovarian and breast tumors, are induced to become tumor-associated fibroblasts and vascular stromal cells, and promote tumor progression [16].”
BackgroundCancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast Cancer
Lee, Y. T., Tan, Y. J., Falasca, M., & Oon, C. E. (2020) · Cancers · doi:10.3390/cancers12102949 · Cited by 51
Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3
Schmohl, K. A., Müller, A. M., Wechselberger, A., Rühland, S., Salb, N., Schwenk, N., Heuer, H., Carlsen, J., Göke, B., Nelson, P. J., et al. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0245 · Cited by 51
Kasashima, H., Yashiro, M., Nakamae, H., Kitayama, K., Masuda, G., Kinoshita, H., Fukuoka, T., Hasegawa, T., Nakane, T., Hino, M., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.07.024 · Cited by 53
Kurashige, M., Kohara, M., Ohshima, K., Tahara, S., Hori, Y., Nojima, S., Wada, N., Ikeda, J., Miyamura, K., Ito, M., et al. (2018) · Communications Biology · doi:10.1038/s42003-018-0137-0 · Cited by 56
Papait, A., Stefani, F. R., Cargnoni, A., Magatti, M., Parolini, O., & Silini, A. R. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00447 · Cited by 50
Role of tissue microenvironment resident adipocytes in colon cancer
Tabuso, M., Homer‐Vanniasinkam, S., Adya, R., & Arasaradnam, R. P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i32.5829 · Cited by 51
Disrupting the Networks of Cancer
Camacho, D. F., & Pienta, K. J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0366 · Cited by 52
“Strategies that inhibit other non-essential host cells such as tumor associated macrophages and cancer associated fibroblasts are being studied(52, 53).”
BackgroundMesenchymal Progenitors Expressing TRAIL Induce Apoptosis in Sarcomas
Grisendi, G., Spano, C., D'souza, N., Rasini, V., Veronesi, E., Prapa, M., Petrachi, T., Piccinno, S., Rossignoli, F., Burns, J. S., et al. (2015) · STEM CELLS · doi:10.1002/stem.1903 · Cited by 48
Intra-Abdominal Fat Depots Represent Distinct Immunomodulatory Microenvironments: A Murine Model
Cohen, C. A., Shea, A. A., Heffron, C. L., Schmelz, E. M., & Roberts, P. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066477 · Cited by 58
“Adiposeassociated stem and progenitor cells have been implicated in various biological processes and pathological conditions [37,38].”
BackgroundYang, X. L., Hao, J., Mao, Y., Jin, Z., Cao, R., Zhu, C.-H., Liu, X., Liu, C., Ding, X.-L., Wang, X., et al. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0217 · Cited by 52
Hypoxia Enhances the Radioresistance of Mouse Mesenchymal Stromal Cells
Sugrue, T., Lowndes, N. F., & Ceredig, R. (2014) · Stem Cells · doi:10.1002/stem.1683 · Cited by 50
Kidney cancer cells secrete IL-8 to activate Akt and promote migration of mesenchymal stem cells
Bi, L., Zhou, N., Cheng, L., Lu, F., Tian-Xin, L., Xuan, X., Chun, J., Jin-li, H., Huang, H. W., Zhang, C., et al. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2013.10.018 · Cited by 48
Harnessing mesenchymal stem cell homing as an anticancer therapy
Hagenhoff, A., Bruns, C. J., Zhao, Y., von Lüttichau, I., Niess, H., Spitzweg, C., & Nelson, P. J. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1196179 · Cited by 47
Li, J., Hao, Y., Mao, W., Xue, X., Xu, P., Liu, L., Yuan, J., Zhang, D., Li, N., Chen, H., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0707-8 · Cited by 47
Spatial multiplexing and omics
Carstens, J. L., Krishnan, S., Rao, A. U. K., Sorace, A. G., Seeley, E. H., Borgogno, S. F., & Burks, J. K. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00330-6 · Cited by 81
“In PET imaging, the positron range remains the resolution-limiting factor, despite advances in technology.”
Self-citationFang, J., Chen, F., Liu, D., Gu, F., & Wang, Y. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01955-6 · Cited by 55
“vascular endothelial cells, fibroblasts, and pericytes [85, 86].”
Group Young Researchers in Inflammatory Carcinogenesis, Wandmacher, A. M., Mehdorn, A., & Sebens, S. (2021) · Cancers · doi:10.3390/cancers13194932 · Cited by 58
Fate of Intravenously Injected Mesenchymal Stem Cells and Significance for Clinical Application
Wagner, B., & Henschler, R. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_155 · Cited by 50
“[37] investigated potential phenotypes of tumor-associated MSCs by multicolored tissue transplant procedures in mice [37].”
BackgroundClassification and biology of tumour associated stromal cells
Raffaghello, L., & Dazzi, F. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.06.016 · Cited by 66
Metastasis-associated fibroblasts in peritoneal surface malignancies
Ramos, C., Gerakopoulos, V., & Oehler, R. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02717-4 · Cited by 46
“Furthermore, it was shown in an ovarian cancer mouse model that adipose-derived α -SMA + stroma is the preferred engraftment location for peritoneal metastasis formation [103].”
BackgroundOvarian ascites-derived Hospicells promote angiogenesis via activation of macrophages
Castells, M., Thibault, B., Mery-Lamarche, E., Golzio, M., Pasquet, M., Hennebelle, I., Bourin, P., Mirshahi, M., Delord, J. P., Querleu, D., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.020 · Cited by 49
Kornblau, S. M., Ruvolo, P. P., Wang, R., Battula, V. L., Shpall, E. J., Ruvolo, V. R., McQueen, T. J., Qui, Y., Zeng, Z., Pierce, S. A., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.172429 · Cited by 43
“Depending on the type, MSC can act either to support or suppress tumors.(4,8-15) Our group and others have found that MSC support leukemia cell survival by diverse mechanisms that include secretion of cytokines and chemokines, activation of survival signaling in tumor cells, and blocking immune surveillance by suppres…”
BackgroundSelf-citationEndothelial Cell Mechano-Metabolomic Coupling to Disease States in the Lung Microvasculature
Wu, D., & Birukov, K. G. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00172 · Cited by 48
“, 2007a) and contributes to fibroblast stroma in a breast cancer model (Kidd et al., 2012).”
BackgroundCohen, C. A., Shea, A. A., Heffron, C. L., Schmelz, E. M., & Roberts, P. C. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0227 · Cited by 48
“These cells are recruited from adipose tissue and bone marrow in order to provide crucial growth factors, matrices, cytokines and nutrients in order to support rapid tumor growth (47,48).”
Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies
Mancini, S. J. C., Balabanian, K., Corre, I., Gavard, J., Lazennec, G., Bousse‐Kerdilès, M. L., Louache, F., Maguer‐Satta, V., Mazure, N. M., Mechta‐Grigoriou, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.766275 · Cited by 46
“Several studies have shown that BM or adipose MSCs [called adipose-derived stromal cells (ADSCs)] have a particular tropism for primary tumors (81, 82).”
BackgroundBen‐Shmuel, A., Gruper, Y., Halperin, C., Levi-Galibov, O., Rosenberg-Fogler, H., Barki, D., Carradori, G., Stein, Y., Yagel, G., Naumova, M., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0131 · Cited by 63
Izar, B., Joyce, C. E., Goff, S. L., Cho, N. L., Shah, P., Sharma, G., Li, J., Ibrahim, N., Gold, J. S., Hodi, F. S., et al. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12513 · Cited by 43
“Interestingly, CAFs appear to have multiple origins, including stem cells from the bone marrow, resident fibroblasts in the tissue surrounding the tumor, and other mesenchymal cells (Guo et al., 2008; Hinz et al., 2007; Ishii et al., 2003; Kidd et al., 2012; Mishra et al., 2008).”
BackgroundBlocki, A. M., Beyer, S., Jung, F., & Raghunath, M. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189132 · Cited by 42
Vera, N., Acuña‐Gallardo, S., Grünenwald, F., Cáceres‐Verschae, A., Realini, O., Acuña, R. A., Lladser, Á., Illanes, S. E., & Varas‐Godoy, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20204972 · Cited by 41
Ganguly, K., Cox, J. L., Ghersi, D., Grandgenett, P. M., Hollingsworth, M. A., Jain, M., Kumar, S., & Batra, S. K. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.02.032 · Cited by 41
Adipose tissue-to-breast cancer crosstalk: Comprehensive insights
Wu, Y., Li, X., Li, Q., Cheng, C., & Zheng, L. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188800 · Cited by 43
Meng, Q., Luo, X., Chen, J., Wang, D., Chen, E., Zhang, W., Zhang, G., Zhou, W., Xu, J., & Song, Z. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188443 · Cited by 39
Dzobo, K., Vogelsang, M., Thomford, N. E., Dandara, C., Kallmeyer, K., Pepper, M. S., & Parker, M. I. (2016) · Stem Cells International · doi:10.1155/2016/4842134 · Cited by 39
“In addition, MSCs have received attention for their role in tumour growth and metastasis [10–13].”
The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer
Bunnell, B. A., Martin, E. C., Matossian, M. D., Brock, C. K., Nguyen, K., Collins‐Burow, B. M., & Burow, M. E. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10063-1 · Cited by 41
Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer
Sax, M. J., Gasch, C., Athota, V. R., Freeman, R., Rasighaemi, P., Westcott, D. E., Day, C. J., Nikolić, I., Elsworth, B., Wei, M. Q., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13387 · Cited by 41
Non-glycanated Decorin Is a Drug Target on Human Adipose Stromal Cells
Daquinag, A. C., Dadbin, A., Snyder, B., Wang, X., Şahin, A. A., Ueno, N. T., & Kolonin, M. G. (2017) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2017.05.003 · Cited by 37
Sequeira, G. R., Sahores, A., Dalotto‐Moreno, T., Perrotta, R. M., Pataccini, G., Vanzulli, S. I., Polo, M. L., Radisky, D. C., Sartorius, C. A., Novaro, V., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1441 · Cited by 39
“The advantage of the NSG-Rmodel is that engrafted cells are easily detected in the host bymeans of GFP staining but they also preserve residual NSG-BM activity, related to the mesenchymal contributions of endothelial cells, fibroblasts, pericytes, and macrophages (33, 34).”
BackgroundRibeiro, R., Monteiro, C., Silvestre, R., Castela, Â., Coutinho, H., Fraga, A., Príncipe, P., Lobato, C., Costa, C., Cordeiro-da-Silva, A., et al. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.012131 · Cited by 37
Fibroblast activation and senescence in oral cancer
Prime, S. S., Cirillo, N., Hassona, Y. M., Lambert, D., Paterson, I. C., Mellone, M., Thomas, G. J., James, E. N., & Parkinson, E. K. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12456 · Cited by 43
Trivanović, D. I., Nikolić, S., Krstić, J., Jauković, A., Mojsilović, S. B., Ilić, V. L., Djordjević, I. O., Santibanez, J. F., Jovčić, G., & Bugarski, D. S. (2013) · Cell Biology International · doi:10.1002/cbin.10198 · Cited by 41
“…promoted tumour cell growth in direct cell-to-cell interactions, a previously reported ability of the tumour cells to induce reactive stromal cells, which later support tumour cell growth (Kidd et al., 2012; Zhao et al., 2012), could not be excluded as a mechanism involved in the observed effect.”
BackgroundValle, P. R. D., Milani, C., Brentani, M. M., Katayama, M. L. H., de Lyra, E. C., Carraro, D. M., Brentani, H., Puga, R., Lima, L. A., Rozenchan, P. B., et al. (2014) · Genetics and Molecular Biology · doi:10.1590/s1415-47572014000400002 · Cited by 36
“The majority of studies that have investigated the origin of cancer fibroblasts have used mice (Quante et al., 2011; Kidd et al., 2012) and their findings are sometimes difficult to translate to humans.”
BackgroundArming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come?
Golinelli, G., Mastrolia, I., Aramini, B., Masciale, V., Pinelli, M., Pacchioni, L., Casari, G., Dall’Ora, M., Soares, M. B. P., Damasceno, P. K. F., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.529921 · Cited by 37
Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer
Morgan, A. G., Griffin, M., Kameni, L. E., Wan, D. C., Longaker, M. T., & Norton, J. A. (2023) · Biology · doi:10.3390/biology12081044 · Cited by 44
Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice
Conti, L., Ruiu, R., Barutello, G., Macagno, M., Bandini, S., Cavallo, F., & Lanzardo, S. (2014) · BioMed Research International · doi:10.1155/2014/534969 · Cited by 45
“In this context, we have recently demonstrated that both ECs and cancer cells in mammary tumors arising in BALB-neuT mice express 𝛼V𝛽3 integrin, a receptor for several extracellular matrix proteins which harbor an arginine-glycine-aspartic acid (RGD) sequence [98].”
BackgroundInfluentialChoi, S., Yu, J., Kim, W., & Park, K. (2021) · Theranostics · doi:10.7150/thno.59703 · Cited by 37
“Similar to cells in wounds that recruit bone marrow-derived mesenchymal stem cells (BM-MSCs) for healing wounds, cells in different types of tumors, including those of ovary, pancreas, prostate, gastrointestinal tissue, and breast, recruit mesenchymal stem cells and progenitors from the bone marrow, and the BM-MSCs re…”
BackgroundFarhat, J., Pandey, I., & Alwahsh, M. (2021) · Cells · doi:10.3390/cells10071657 · Cited by 38
“Stromal and tumor cell crosstalk constitutes the base for the promotion of a well-organized TME, reaching effective immune evasion, ECM remodeling, and angiogenesis [48].”
BackgroundMesenchymal Stem Cell-Derived Microparticles: A Promising Therapeutic Strategy
Tan, X., Gong, Y.-Z., Wu, P., Liao, D., & Zheng, X. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150814348 · Cited by 37
“In addition, various studies indicate that MSCs are the potential sources of tumor-associated fibroblasts [48].”
BackgroundOo, M. W., Kawai, H., Takabatake, K., Tomida, S., Eguchi, T., Ono, K., Shan, Q., Ohara, T., Yoshida, S., Omori, H., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.148960 · Cited by 35
“However, the potential for BMDCs to differentiate into CAFs (αSMA+) and TECs (CD34+) is highly variable and depends on tumor type, organ location, and tumor development stage (37, 38).”
BackgroundCancer‐associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?
Aden, D., Zaheer, S., Ahluwalia, H., & Ranga, S. (2023) · Cell Biology International · doi:10.1002/cbin.12004 · Cited by 33
“, 2021), or trans‐differentiate from adipocytes (Kidd et al., 2012), mesothelial cells (Rynne‐Vidal et al.”
Background3D bioprinting technology to mimic the tumor microenvironment: tumor-on-a-chip concept
Samadian, H., Jafari, S., Sepand, M. R., Alaei, L., Malvajerd, S. S., Jaymand, M., Ghobadinezhad, F., Jahanshahi, F., Hamblin, M. R., Derakhshankhah, H., et al. (2021) · Materials Today Advances · doi:10.1016/j.mtadv.2021.100160 · Cited by 37
Lawrenson, K., Grün, B., Lee, N., Mhawech-Fauceglia, P. Y., Kan, J., Swenson, S. D., Lin, Y. G., Pejovic, T. B., Millstein, J., & Gayther, S. A. (2014) · International Journal of Cancer · doi:10.1002/ijc.29092 · Cited by 34
“Recent evidence suggests that bone-marrow-derived MSCs make a substantial contribution to CAF population in a syngeneic ovarian cancer mouse model.(11,15) We addressed the hypothesis that immortalised normal ovarian fibroblasts (INOFs) and/or bonemarrow-derived human MSCs represent origins of ovarian CAFs by performin…”
BackgroundResultInfluentialIntegrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis
Schmohl, K. A., Mueller, A. M., Dohmann, M., Spellerberg, R., Urnauer, S., Schwenk, N., Ziegler, S. I., Bartenstein, P., Nelson, P. J., & Spitzweg, C. (2019) · Thyroid · doi:10.1089/thy.2019.0413 · Cited by 43
From nature to clinic: Quercetin’s role in breast cancer immunomodulation
Fang, L., Gao, D., Wang, T., Zhao, H., Zhang, Y., & Wang, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1483459 · Cited by 36
Thiery, J. (2022) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2022.00103 · Cited by 33
Tumor-driven Molecular Changes in Human Mesenchymal Stromal Cells
Kučerová, L., Zmajkovic, J., Toro, L., Miklikova, S., Demková, L., & Matúšková, M. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0151-9 · Cited by 31
Vandsburger, M. H., Radoul, M., Addadi, Y., Mpofu, S., Cohen, B., Eilam, R., & Neeman, M. (2013) · Radiology · doi:10.1148/radiol.13122053 · Cited by 29
“The recruitment of fibroblasts from local or remote tissues by tumors is a critical aspect of tumor growth and metastasis (1,2).”
Tracking Inflammation-Induced Mobilization of Mesenchymal Stem Cells
Spaeth, E. L., Kidd, S. M., & Marini, F. C. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-943-3_15 · Cited by 29
Self-citationCells As Delivery Vehicles for Cancer Therapeutics
Basel, M. T., Shrestha, T. B., Bossmann, S. H., & Troyer, D. L. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.24 · Cited by 28
Metadata
- Authors
- Kidd, S., Spaeth, E., Watson, K., Burks, J., Lu, H., Klopp, A., Andreeff, M., & Marini, F. C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Marini, Frank C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-02-20
- Volume
- 7
- Issue
- 2
- Pages
- e30563
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3282707
- OpenAlex
- W1972938311
- Cited by
- 371
- References
- 58
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 19 · 2023: 32 · 2022: 24 · 2021: 30 · 2020: 23 · 2019: 29 · 2018: 22 · 2017: 21 · 2016: 30 · 2015: 32 · 2014: 34 · 2013: 44 · 2012: 18
- FWCI
- 20.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Defense
- Ovarian Cancer Research Fund
- Susan G. Komen (BC083397)
- National Cancer Institute (P50CA116199, CA-16672, CA-55164, R01CA109451, P01CA049639, R01NS06994, P01CA055164, Ca-116199, RC1CA146381, BC083397, CA109451, P50CA083639, P30CA016672, CA 49639)
- National Institute of Neurological Disorders and Stroke (R01NS069964, R01NS06994)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- tumor microenvironment, cancer-associated fibroblasts, mesenchymal stem cells, pericytes, myofibroblasts, endothelial cells, fibroblast activation protein, ovarian neoplasms, breast tumors, tissue transplantation
- MeSH terms
- Adipose Tissue, Animals, Bone Marrow Cells, Female, Mice, Inbred C57BL, Models, Biological, Biomarkers, Cell Line, Tumor, Green Fluorescent Proteins, Mice, Tumor Microenvironment, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.